Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-106,300
Closed -$491K 11221
2019
Q1
$491K Buy
106,300
+81,500
+329% +$386K ﹤0.01% 6324
2018
Q4
$87K Sell
24,800
-168,400
-87% -$1.17M ﹤0.01% 8281
2018
Q3
$1.95M Sell
193,200
-61,200
-24% -$488K ﹤0.01% 4041
2018
Q2
$1.84M Buy
254,400
+64,200
+34% +$448K ﹤0.01% 4148
2018
Q1
$1.15M Buy
190,200
+60,700
+47% +$501K ﹤0.01% 4964
2017
Q4
$1.25M Sell
129,500
-46,100
-26% -$302K ﹤0.01% 4799
2017
Q3
$1.56M Sell
175,600
-200
-0.1% -$2.06K ﹤0.01% 4380
2017
Q2
$2.22M Sell
175,800
-25,600
-13% -$303K ﹤0.01% 3731
2017
Q1
$2.12M Buy
201,400
+74,300
+58% +$792K ﹤0.01% 3625
2016
Q4
$1.17M Buy
127,100
+19,000
+18% +$215K ﹤0.01% 5184
2016
Q3
$1.27M Buy
108,100
+34,600
+47% +$526K ﹤0.01% 4341
2016
Q2
$951K Sell
73,500
-169,000
-70% -$2.46M ﹤0.01% 4981
2016
Q1
$3.88M Sell
242,500
-36,400
-13% -$691K ﹤0.01% 2657
2015
Q4
$7.99M Buy
278,900
+73,600
+36% +$2.04M ﹤0.01% 1986
2015
Q3
$5.84M Sell
205,300
-88,800
-30% -$3.27M ﹤0.01% 2459
2015
Q2
$10.6M Buy
294,100
+100,500
+52% +$3.13M ﹤0.01% 1938
2015
Q1
$5.63M Sell
193,600
-96,400
-33% -$2.55M ﹤0.01% 2573
2014
Q4
$6.11M Sell
290,000
-16,200
-5% -$320K ﹤0.01% 2612
2014
Q3
$5.94M Buy
306,200
+209,000
+215% +$3.28M ﹤0.01% 2777
2014
Q2
$1.52M Sell
97,200
-36,300
-27% -$587K ﹤0.01% 5213
2014
Q1
$2.77M Buy
133,500
+61,800
+86% +$1.23M ﹤0.01% 3782
2013
Q4
$925K Buy
+71,700
New +$994K ﹤0.01% 5646

Other funds holding INSY

Susquehanna International Group's INSY Position: Q2 2019 in Review

Susquehanna International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.

Susquehanna International Group first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Susquehanna International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
  • Susquehanna International Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
  • Susquehanna International Group's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.